Raymond James Financial Inc Tekla Life Sciences Investors Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Raymond James Financial Inc holds 312,531 shares of HQL stock, worth $3.98 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
312,531
Previous 238,470
31.06%
Holding current value
$3.98 Million
Previous $3.13 Million
26.79%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HQL
# of Institutions
91Shares Held
9.06MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.19MShares$40.6 Million1.12% of portfolio
-
Penserra Capital Management LLC Orinda, CA747KShares$9.51 Million0.17% of portfolio
-
Morgan Stanley New York, NY519KShares$6.6 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY468KShares$5.95 Million0.25% of portfolio
-
Needham Investment Management LLC New York, NY379KShares$4.82 Million0.5% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...